Category News

Ventus Therapeutics Highlights Caspase-4/5 as Promising Therapeutic Targets in Nature Reviews Immunology

Ventus Therapeutics Highlights Caspase-4/5 as Promising Therapeutic Targets in Nature Reviews Immunology Ventus Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel small-molecule therapies for immunological, inflammatory, and neurological disorders,…

Read MoreVentus Therapeutics Highlights Caspase-4/5 as Promising Therapeutic Targets in Nature Reviews Immunology